PAIN
Volume 148, Issue 1 , Pages 26-35, January 2010

Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids

  • Alejandro Telleria-Diaz

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • These authors contributed equally to this work.
  • ,
  • Martin Schmidt

      Affiliations

    • Department of Biochemistry, University Hospital of Jena, Nonnenplan 2, D-07740 Jena, Germany
    • These authors contributed equally to this work.
  • ,
  • Stefan Kreusch

      Affiliations

    • Department of Biochemistry, University Hospital of Jena, Nonnenplan 2, D-07740 Jena, Germany
  • ,
  • Anne-Kathrin Neubert

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
  • ,
  • Florian Schache

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
  • ,
  • Enrique Vazquez

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • On leave from the Instituto Venezolano de Investigaciones Cientificas (IVIC), Caracas, Venezuela.
  • ,
  • Horacio Vanegas

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • On leave from the Instituto Venezolano de Investigaciones Cientificas (IVIC), Caracas, Venezuela.
  • ,
  • Hans-Georg Schaible

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
  • ,
  • Andrea Ebersberger

      Affiliations

    • Department of Physiology, University Hospital of Jena, Teichgraben 8, D-07740 Jena, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 3641 938814; fax: +49 3641 938812.

Received 16 February 2009; received in revised form 12 August 2009; accepted 17 August 2009. published online 30 October 2009.

Abstract 

Both cyclooxygenase-1 and -2 are expressed in the spinal cord, and the spinal COX product prostaglandin E2 (PGE2) contributes to the generation of central sensitization upon peripheral inflammation. Vice versa spinal COX inhibition is considered an important mechanism of antihyperalgesic pain treatment. Recently, however, COX-2 was shown to be also involved in the metabolism of endocannabinoids. Because endocannabinoids can have analgesic actions it is conceivable that inhibition of spinal COX produces analgesia not only by inhibition of PG synthesis but also by inhibition of endocannabinoid breakdown. In the present study, we recorded from spinal cord neurons with input from the inflamed knee joint and we measured the spinal release of PGE2 and the endocannabinoid 2-arachidonoyl glycerol (2-AG) in vivo, using the same stimulation procedures. COX inhibitors were applied spinally. Selective COX-1, selective COX-2 and non-selective COX inhibitors attenuated the generation of spinal hyperexcitability when applied before and during development of inflammation but, when inflammation and spinal hyperexcitability were established, only selective COX-2 inhibitors reversed spinal hyperexcitability. During established inflammation all COX inhibitors reduced release of spinal PGE2 almost equally but only the COX-2 inhibitor prevented breakdown of 2-AG. The reversal of spinal hyperexcitability by COX-2 inhibitors was prevented or partially reversed by AM-251, an antagonist at the cannabinoid-1 receptor. We conclude that inhibition of spinal COX-2 not only reduces PG production but also endocannabinoid breakdown and provide evidence that reversal of inflammation-evoked spinal hyperexcitability by COX-2 inhibitors is more related to endocannabinoidergic mechanisms than to inhibition of spinal PG synthesis.

Keywords: Pain, Nociception, Inflammation, Central sensitization, Spinal cord, Prostaglandins

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3959(09)00460-6

doi:10.1016/j.pain.2009.08.013

Refers to article:

  • CB1-induced side effects of specific COX-2 inhibitors: A feature, not a bug , 16 November 2009

    Heather Bradshaw
    PAIN January 2010 (Vol. 148, Issue 1, Page 5)

PAIN
Volume 148, Issue 1 , Pages 26-35, January 2010